Vranken Pommery Monopole SA
PAR:VRAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vranken Pommery Monopole SA
PAR:VRAP
|
FR |
|
Condor Energies Inc
TSX:CDR
|
CA |
|
B
|
BioDelivery Sciences International Inc
F:BD5
|
US |
|
A
|
Al-Saif Stores for Development & Investment Company SJSC
SAU:4192
|
SA |
|
N
|
NewGLab Pharma Co Ltd
KOSDAQ:214870
|
KR |
|
F
|
FG Merger II Corp
NASDAQ:FGMC
|
US |
|
R
|
Royal Orchid Hotel Thailand PCL
SET:ROH
|
TH |
|
Pharmaust Ltd
ASX:PAA
|
AU |
|
IGEA Pharma NV
SIX:IGPH
|
NL |
|
Chaoda Modern Agriculture Holdings Ltd
HKEX:682
|
HK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VRAP's stock price target?
Not Available
VRAP doesn't have any price targets made by Wall Street professionals.
What is Vranken Pommery Monopole SA's Revenue forecast?
Projected CAGR
3%
For the last 13 years the
compound annual growth rate for
Vranken Pommery Monopole SA's revenue is
-1%.
The projected
CAGR
for the next 3 years is
3%.
What is Vranken Pommery Monopole SA's Operating Income forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
Vranken Pommery Monopole SA's operating income is
-1%.
The projected
CAGR
for the next 3 years is
6%.
What is Vranken Pommery Monopole SA's Net Income forecast?
Projected CAGR
96%
For the last 13 years the
compound annual growth rate for
Vranken Pommery Monopole SA's net income is
-16%.
The projected
CAGR
for the next 3 years is
96%.
